CIK: 0001595851 · Show all filings
Period: Q1 2014 (← Previous) (Next →)
Filing Date: May 15, 2014
Total Value: $168M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ISHARES | 150,000 | $17.45M | 10.4% | — | — | Put | 464287955 |
| — | MERCK & CO INC NEW | 250,000 | $14.19M | 8.4% | — | — | Call | 58933Y905 |
| — | TEVA PHARMACEUTICAL INDS LTD | 150,000 | $7.926M | 4.7% | — | — | Call | 881624909 |
| — | GILEAD SCIENCES INC | 100,000 | $7.086M | 4.2% | — | — | Call | 375558903 |
| — | BRISTOL MYERS SQUIBB CO | 100,000 | $5.195M | 3.1% | — | — | Call | 110122908 |
| — | MYLAN INC | 100,000 | $4.883M | 2.9% | — | — | Call | 628530907 |
| — | AEGERION PHARMACEUTICALS INC | 100,000 | $4.618M | 2.7% | — | — | Call | 00767E902 |
| — | VERTEX PHARMACEUTICALS INC | 65,000 | $4.597M | 2.7% | — | — | Call | 92532F900 |
| PRTA | PROTHENA CORP PLC | 110,000 | $4.214M | 2.5% | $25.08 | +28.5% | SHS | G72800108 |
| BMY | BRISTOL MYERS SQUIBB CO | 80,000 | $4.156M | 2.5% | $34.16 | +5.2% | COM | 110122108 |
| — | FLAMEL TECHNOLOGIES SA | 300,000 | $4.02M | 2.4% | $11.26 | — | SPONSORED ADR | 338488109 |
| ARAY | ACCURAY INC | 400,018 | $3.84M | 2.3% | $7.76 | +21.8% | COM | 004397105 |
| — | INSMED INC | 200,000 | $3.808M | 2.3% | — | — | Call | 457669907 |
| — | AMAG PHARMACEUTICALS INC | 192,057 | $3.716M | 2.2% | $19.35 | — | COM | 00163U106 |
| — | CHELSEA THERAPEUTICS INTL LT | 600,000 | $3.312M | 2.0% | $5.34 | — | COM | 163428105 |
| — | UNILIFE CORP NEW | 800,000 | $3.256M | 1.9% | $4.21 | — | COM | 90478E103 |
| CYH | COMMUNITY HEALTH SYS INC NEW | 80,000 | $3.134M | 1.9% | $34.19 | -3.4% | COM | 203668108 |
| — | ARROWHEAD RESH CORP | 185,000 | $3.038M | 1.8% | $10.85 | — | COM NEW | 042797209 |
| — | AFFYMETRIX INC | 425,000 | $3.03M | 1.8% | $7.13 | — | NOTE 4.000% 7/0 | 00826TAH1 |
| — | TORNIER N V | 130,000 | $2.759M | 1.6% | $19.35 | — | SHS | N87237108 |
| — | INTERCEPT PHARMACEUTICALS IN | 8,000 | $2.638M | 1.6% | $329.75 | — | COM | 45845P108 |
| INSM | INSMED INC | 135,000 | $2.57M | 1.5% | $15.31 | +24.1% | COM PAR $.01 | 457669307 |
| — | TANDEM DIABETES CARE INC | 115,000 | $2.54M | 1.5% | $23.53 | — | COM | 875372104 |
| MMSI | MERIT MED SYS INC | 175,000 | $2.503M | 1.5% | $14.85 | 0.0% | COM | 589889104 |
| — | OCERA THERAPEUTICS INC | 235,000 | $2.479M | 1.5% | $11.33 | — | COM | 67552A108 |
| — | FURIEX PHARMACEUTICALS INC | 27,500 | $2.393M | 1.4% | $87.02 | — | COM | 36106P101 |
| EW | EDWARDS LIFESCIENCES CORP | 30,000 | $2.225M | 1.3% | $11.54 | 0.0% | COM | 28176E108 |
| ISRG | INTUITIVE SURGICAL INC | 5,000 | $2.19M | 1.3% | $47.10 | 0.0% | COM NEW | 46120E602 |
| BRKR | BRUKER CORP | 90,000 | $2.051M | 1.2% | $18.83 | +11.2% | COM | 116794108 |
| BIIB | BIOGEN IDEC INC | 6,471 | $1.979M | 1.2% | $258.65 | +22.7% | COM | 09062X103 |
| — | HORIZON PHARMA INC | 130,000 | $1.966M | 1.2% | $9.35 | — | COM | 44047T109 |
| ALGN | ALIGN TECHNOLOGY INC | 35,000 | $1.813M | 1.1% | $55.98 | 0.0% | COM | 016255101 |
| — | DYAX CORP | 200,000 | $1.796M | 1.1% | $7.54 | — | COM | 26746E103 |
| — | CONATUS PHARMACEUTICALS INC | 219,977 | $1.79M | 1.1% | $8.14 | — | COM | 20600T108 |
| — | CHELSEA THERAPEUTICS INTL LT | 300,000 | $1.656M | 1.0% | — | — | Call | 163428905 |
| ATRC | ATRICURE INC | 85,000 | $1.599M | 0.9% | $20.49 | 0.0% | COM | 04963C209 |
| SGMO | SANGAMO BIOSCIENCES INC | 86,606 | $1.566M | 0.9% | $11.51 | +67.4% | COM | 800677106 |
| — | NANOSTRING TECHNOLOGIES INC | 75,000 | $1.549M | 0.9% | $20.65 | — | COM | 63009R109 |
| — | SPECTRANETICS CORP | 50,000 | $1.516M | 0.9% | $25.00 | — | COM | 84760C107 |
| ILMN | ILLUMINA INC | 10,000 | $1.487M | 0.9% | $146.95 | 0.0% | COM | 452327109 |
| — | GW PHARMACEUTICALS PLC | 25,000 | $1.484M | 0.9% | $59.36 | — | ADS | 36197T103 |
| — | DEPOMED INC | 100,000 | $1.45M | 0.9% | $12.54 | — | COM | 249908104 |
| — | LANNET INC | 40,000 | $1.429M | 0.8% | $33.10 | — | COM | 516012101 |
| ENTA | ENANTA PHARMACEUTICALS INC | 35,000 | $1.4M | 0.8% | $36.32 | 0.0% | COM | 29251M106 |
| — | THERAPEUTICSMD INC | 200,000 | $1.262M | 0.7% | $6.31 | — | COM | 88338N107 |
| PBYI | PUMA BIOTECHNOLOGY INC | 11,330 | $1.18M | 0.7% | $58.69 | +100.3% | COM | 74587V107 |
| — | NUVASIVE INC | 30,000 | $1.152M | 0.7% | $38.40 | — | COM | 670704105 |
| — | EPIZYME INC | 45,000 | $1.025M | 0.6% | $22.78 | — | COM | 29428V104 |
| — | KYTHERA BIOPHARMACEUTICALS I | 25,000 | $994K | 0.6% | $39.76 | — | COM | 501570105 |
| — | ANTARES PHARMA INC | 250,000 | $875K | 0.5% | $3.50 | — | COM | 036642106 |
| — | TEARLAB CORP | 125,000 | $845K | 0.5% | $9.34 | — | COM | 878193101 |
| — | NXSTAGE MEDICAL INC | 62,500 | $796K | 0.5% | $10.00 | — | COM | 67072V103 |
| — | ENTEROMEDICS INC | 400,000 | $728K | 0.4% | $1.82 | — | COM NEW | 29365M208 |
| — | BIOLASE INC | 300,000 | $723K | 0.4% | $2.41 | — | COM | 090911108 |
| — | FLEXION THERAPEUTICS INC | 40,000 | $658K | 0.4% | $16.45 | — | COM | 33938J106 |
| — | REVANCE THERAPEUTICS INC | 20,000 | $630K | 0.4% | $31.50 | — | COM | 761330109 |
| — | AMARIN CORP PLC | 300,000 | $543K | 0.3% | $1.81 | — | SPONS ADR NEW | 023111206 |
| — | NOVAVAX INC | 100,000 | $453K | 0.3% | $4.53 | — | COM | 670002104 |
| CPRX | CATALYST PHARM PARTNERS INC | 200,000 | $452K | 0.3% | $2.03 | +3.0% | COM | 14888U101 |
| — | DYNAVAX TECHNOLOGIES CORP | 247,340 | $447K | 0.3% | $1.96 | — | COM | 268158102 |
| — | ANACOR PHARMACEUTICALS INC | 20,000 | $400K | 0.2% | $20.00 | — | COM | 032420101 |
| SRNE | SORRENTO THERAPEUTICS INC | 30,000 | $385K | 0.2% | $11.07 | 0.0% | COM NEW | 83587F202 |
| — | DURECT CORP | 250,000 | $333K | 0.2% | $1.33 | — | COM | 266605104 |
| — | IGNYTA INC | 23,500 | $195K | 0.1% | $8.30 | — | COM | 451731103 |
| — | WRIGHT MED GROUP INC | 55,150 | $46,000 | 0.0% | $0.33 | — | RIGHT 03/01/2019 | 98235T115 |